BTG Pactual Global Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-59,764
| Closed | -$11M | – | 100 |
|
2021
Q2 | $11M | Buy |
59,764
+13,000
| +28% | +$2.39M | 2.88% | 2 |
|
2021
Q1 | $7.15M | Buy |
46,764
+13,000
| +39% | +$1.99M | 1.93% | 6 |
|
2020
Q4 | $5.28M | Buy |
+33,764
| New | +$5.28M | 0.74% | 5 |
|
2018
Q4 | – | Sell |
-1,984
| Closed | -$276K | – | 61 |
|
2018
Q3 | $276K | Sell |
1,984
-3,077
| -61% | -$428K | 0.12% | 42 |
|
2018
Q2 | $628K | Buy |
5,061
+328
| +7% | +$40.7K | 0.18% | 50 |
|
2018
Q1 | $528K | Buy |
4,733
+966
| +26% | +$108K | 0.14% | 49 |
|
2017
Q4 | $450K | Buy |
3,767
+127
| +3% | +$15.2K | 0.16% | 41 |
|
2017
Q3 | $511K | Sell |
3,640
-228
| -6% | -$32K | 0.16% | 49 |
|
2017
Q2 | $471K | Buy |
3,868
+967
| +33% | +$118K | 0.14% | 54 |
|
2017
Q1 | $352K | Buy |
+2,901
| New | +$352K | 0.13% | 59 |
|
2014
Q3 | – | Sell |
-2,200
| Closed | -$344K | – | 277 |
|
2014
Q2 | $344K | Buy |
+2,200
| New | +$344K | 0.05% | 190 |
|